Skip to main content
OpenTrials
Completed

NCT Number: NCT03402672

AWAITS: A Web-based E-health Application for Active Illicit Opioid Users

The purpose of this research study is to:

1. assess how participants like the AWAITS e-health application as measured by their feedback on the intervention 2. test the impact of AWAITS on knowledge about opioid overdose and risk-reduction strategies. 3. assess the proportion of participants who accept a list of local treatment providers 4. test the impact of AWAITS on interest in being tested for HCV/HIV.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Opioid-use Disorder Chemically-Induced Disorders Drug Addiction Drug Misuse Drug Overdose IV Drug Usage Mental Disorders Narcotic-Related Disorders Opioid-Related Disorders Overdose Prescription Drug Misuse Substance Use Disorders Substance-Related Disorders

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

University of Cincinnati Addiction Sciences Division

Cincinnati, Ohio, 45229, United States

About this study

The pre-post study of AWAITS will: 1) assess the acceptability of AWAITS as measured by participant feedback about the intervention; 2) test the impact of AWAITS on knowledge about opioid overdose, as measured by the OOTAS; 3) assess the proportion of participants who accept a list of local MAT treatment providers; and 4) test the impact of AWAITS on interest in being tested for HCV/HIV.

The acceptability of AWAITS will be assessed with a feedback form which includes questions about how helpful the intervention was (scale of 1-4), what the patient liked most and least about the intervention, and any suggestions for improving it. The average (and standard deviation) for the rated helpfulness of the intervention will be derived and the qualitative data about what they liked most and least about the intervention and suggestions for improvement will be tabulated. Pre-/post-changes in the percent of correct knowledge assessment items (i.e., about overdose and MAT) and interest in HCV/HIV testing will be analyzed using a Wilcoxon signed-rank test. The proportion of participants accepting a list of local MAT treatment providers will be calculated.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • At least 18 years of age
  • Not enrolled in MAT per self-report
  • Self-reports illicit opioid use

Exclusion criteria

  • Does not acknowledge reviewing "Information Sheet for Research" within REDCap

Treatment and study plan

self-administered, e-health application

Other

AWAITS is a self-administered, e-health application and includes short videos in which patients who are successfully engaged in MAT discuss what they wish they had known about MAT when they were actively using. The intervention is designed to maximize "scalability" - the administration would entail handing an electronic device (e.g., tablet, laptop, etc.) to an individual who would then self-administer the intervention.

Primary outcomes

  1. 3 sections of the OOTAS (signs of overdose, how to respond to an overdose, and MAT)

    Time frame: Day 1

    To test the impact of AWAITS on knowledge about opioid overdose

Secondary outcomes

  1. Feedback on AWAITS

    Time frame: Day 1

    To assess the acceptability of the intervention

  2. Acceptance of list of MAT providers

    Time frame: Day 1

    Assess relative interest in MAT post-AWAITS

Sponsors and collaborators

Lead sponsor

University of Cincinnati

Other

Registry information

Official study title

A Web-based E-health Application for Active Illicit Opioid Users Providing Information About Overdose and Infection Risk Factors and Encouraging HCV/HIV Testing and Medication Assisted Treatment Seeking

Acronym: AWAITS

Important dates

Study start
2017
Primary completion
2018
Study completion
2018
First posted
Jan 18, 2018
Registry last updated
Apr 10, 2019

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.